Cargando…

Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea

PURPOSE: Adverse events during mass vaccination campaigns have had a profoundly negative impact on vaccine coverage rates. The objective of the study was to identify the characteristics of reported psychogenic illness cases following mass vaccination that needed further interventions of the national...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tae Un, Kim, Hee Jung, Lee, Yeon Kyeong, Park, Young-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292354/
https://www.ncbi.nlm.nih.gov/pubmed/28168171
http://dx.doi.org/10.7774/cevr.2017.6.1.31
_version_ 1782504906122330112
author Yang, Tae Un
Kim, Hee Jung
Lee, Yeon Kyeong
Park, Young-Joon
author_facet Yang, Tae Un
Kim, Hee Jung
Lee, Yeon Kyeong
Park, Young-Joon
author_sort Yang, Tae Un
collection PubMed
description PURPOSE: Adverse events during mass vaccination campaigns have had a profoundly negative impact on vaccine coverage rates. The objective of the study was to identify the characteristics of reported psychogenic illness cases following mass vaccination that needed further interventions of the national immunization program. MATERIALS AND METHODS: We collected documents that were submitted to the Korea Centers for Disease Control and Prevention for vaccine injury compensation, and analyzed cases of psychogenic illness following pandemic influenza A (H1N1) vaccination in 2009 which were confirmed by the Korean Advisory Committee on Vaccine Injury Compensation. RESULTS: During the 2009-2010 influenza season, 13 million Koreans were vaccinated against pandemic influenza. Of 28 reported psychogenic illness cases following immunization, 25 were vaccinated through school-located mass immunization. Significant numbers of them were female adolescents (68%) or had underlying vulnerable conditions or emotional life stressors (36%). They required lengthy hospitalization (median, 7 days) and high medical costs (median, US $1,582 per case). CONCLUSION: Health authorities and organizers of future mass vaccinations should be well aware of the possible occurrence of psychogenic illness, acknowledge their detailed characteristics, and take its economic burden into account to mitigate the risk of transmission of infectious diseases efficiently.
format Online
Article
Text
id pubmed-5292354
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Vaccine Society
record_format MEDLINE/PubMed
spelling pubmed-52923542017-02-06 Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea Yang, Tae Un Kim, Hee Jung Lee, Yeon Kyeong Park, Young-Joon Clin Exp Vaccine Res Original Article PURPOSE: Adverse events during mass vaccination campaigns have had a profoundly negative impact on vaccine coverage rates. The objective of the study was to identify the characteristics of reported psychogenic illness cases following mass vaccination that needed further interventions of the national immunization program. MATERIALS AND METHODS: We collected documents that were submitted to the Korea Centers for Disease Control and Prevention for vaccine injury compensation, and analyzed cases of psychogenic illness following pandemic influenza A (H1N1) vaccination in 2009 which were confirmed by the Korean Advisory Committee on Vaccine Injury Compensation. RESULTS: During the 2009-2010 influenza season, 13 million Koreans were vaccinated against pandemic influenza. Of 28 reported psychogenic illness cases following immunization, 25 were vaccinated through school-located mass immunization. Significant numbers of them were female adolescents (68%) or had underlying vulnerable conditions or emotional life stressors (36%). They required lengthy hospitalization (median, 7 days) and high medical costs (median, US $1,582 per case). CONCLUSION: Health authorities and organizers of future mass vaccinations should be well aware of the possible occurrence of psychogenic illness, acknowledge their detailed characteristics, and take its economic burden into account to mitigate the risk of transmission of infectious diseases efficiently. The Korean Vaccine Society 2017-01 2017-01-25 /pmc/articles/PMC5292354/ /pubmed/28168171 http://dx.doi.org/10.7774/cevr.2017.6.1.31 Text en © Korean Vaccine Society. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yang, Tae Un
Kim, Hee Jung
Lee, Yeon Kyeong
Park, Young-Joon
Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title_full Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title_fullStr Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title_full_unstemmed Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title_short Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea
title_sort psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza a (h1n1) in 2009 in south korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292354/
https://www.ncbi.nlm.nih.gov/pubmed/28168171
http://dx.doi.org/10.7774/cevr.2017.6.1.31
work_keys_str_mv AT yangtaeun psychogenicillnessfollowingvaccinationexploratorystudyofmassvaccinationagainstpandemicinfluenzaah1n1in2009insouthkorea
AT kimheejung psychogenicillnessfollowingvaccinationexploratorystudyofmassvaccinationagainstpandemicinfluenzaah1n1in2009insouthkorea
AT leeyeonkyeong psychogenicillnessfollowingvaccinationexploratorystudyofmassvaccinationagainstpandemicinfluenzaah1n1in2009insouthkorea
AT parkyoungjoon psychogenicillnessfollowingvaccinationexploratorystudyofmassvaccinationagainstpandemicinfluenzaah1n1in2009insouthkorea